Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,562 | 17,724 | 21,201 | 18,009 | 21,695 |
| TOTAL | $14,839 | $18,432 | $22,267 | $19,369 | $22,665 |
| Non-Current Assets | |||||
| PPE Net | 639 | 678 | 713 | 784 | 777 |
| Intangibles | 338 | 380 | 7,787 | 8,298 | 8,586 |
| Other Non-Current Assets | 37 | 64 | 89 | 121 | 151 |
| TOTAL | $1,014 | $1,121 | $8,589 | $9,203 | $9,514 |
| Total Assets | $15,853 | $19,553 | $30,855 | $28,572 | $32,179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,793 | 463 | 710 | 754 | 1,218 |
| Other current liabilities | 1,877 | 1,763 | 1,799 | 1,459 | 764 |
| TOTAL | $4,438 | $3,996 | $2,598 | $2,325 | $2,094 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,008 | 885 | 3,931 | 2,651 | 4,013 |
| TOTAL | $1,008 | $885 | $5,417 | $4,282 | $5,644 |
| Total Liabilities | $5,447 | $4,881 | $8,015 | $6,607 | $7,737 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12 | 12 | 12 | 9 | 6 |
| Common Shares | 21 | 21 | 21 | 11 | 526 |
| Retained earnings | -83,885 | -79,208 | -70,530 | -68,051 | -65,261 |
| Other shareholders' equity | -535 | -537 | -641 | -223 | 58 |
| TOTAL | $10,406 | $14,672 | $22,840 | $21,965 | $24,442 |
| Total Liabilities And Equity | $15,853 | $19,553 | $30,855 | $28,572 | $32,179 |